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Abstract
Background: The purpose of this paper is to describe how end-of-life care is managed when life-support limitation
is decided in a Pediatric Intensive Care Unit and to analyze the influence of the further development of the
Palliative Care Unit.
Methods: A 15-year retrospective study of children who died after life-support limitation was initiated in a pediatric
intensive care unit. Patients were divided into two groups, pre- and post-palliative care unit development.
Epidemiological and clinical data, the decision-making process, and the approach were analyzed. Data was
obtained from patient medical records.
Results: One hundred seventy-five patients were included. The main reason for admission was respiratory failure
(86/175). A previous pathology was present in 152 patients (61/152 were neurological issues). The medical team
and family participated together in the decision-making in 145 cases (82.8%). The family made the request in 10
cases (9 vs. 1, p = 0.019). Withdrawal was the main life-support limitation (113/175), followed by withholding life-
sustaining treatments (37/175). Withdrawal was more frequent in the post-palliative group (57.4% vs. 74.3%, p = 0.031).
In absolute numbers, respiratory support was the main type of support withdrawn.
Conclusions: The main cause of life-support limitation was the unfavourable evolution of the underlying pathology.
Families were involved in the decision-making process in a high percentage of the cases. The development of the
Palliative Care Unit changed life-support limitation in our unit, with differences detected in the type of patient and in
the strategy used. Increased confidence among intensivists when providing end-of-life care, and the availability of a
Palliative Care Unit may contribute to improvements in the quality of end-of-life care.
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Background
Medical care standards in pediatrics are continuously
improving. However, there are still situations in which a
cure or an acceptable quality of life for our patients are
not possible. Even with recent technological advances,
sometimes we can only prolong the process of dying. It
is necessary to weigh whether it is appropriate to main-
tain or begin an established treatment, or whether it
would be more appropriate to remove it or not initiate it
when this treatment is considered non-beneficial [1–3].
Each case should be evaluated individually, with the de-
cision taken by consensus among all the professionals
involved in the patient’s care and the family. The object-
ive is to reach an agreement in which life support tech-
niques/treatments are adapted to the situation of each
patient [4]. The goals of care will thus change to ensure
comfort rather than to provide a cure, and families must
be made to understand that the best care for their child
is being provided [5–7].
There is an increasing interest in end-of-life (EOL)
care. In pediatrics, EOL care has progressively improved,
especially with the development of palliative care that
provides support at home or in the general ward. How-
ever, there are still EOL situations in which the intensi-
vist must assess the futility of the established treatments
and evaluate the appropriateness of a planned withhold-
ing or withdrawal of the life-support interventions if the
patient’s situation so requires [5, 8, 9]. It should be
noted that the clinician is not obliged to maintain a
treatment that he or she considers non-beneficial, but
must always seek consensus, to the best of their ability,
with the family and other health professionals involved
in the patient’s care. The family should be kept well in-
formed, and the physicians must continue to provide the
best possible comprehensive care and symptom manage-
ment, for the family’s sake [3, 10, 11].
Both this study and our prior work [12] contribute to
the wealth of published research regarding EOL in a
Pediatric Intensive Care Unit (PICU), especially that re-
garding withdrawal of life-sustaining treatments. In
2011, a 7-year descriptive review was published by our
institution [12]. The aim of that study was to describe
the EOL decision-making process in a PICU. The
present study aims to describe how EOL care in the
PICU is carried out and how the implementation of pal-
liative care has changed EOL practices in the PICU.
Methods
This is a retrospective study performed in a referral ter-
tiary pediatric hospital from 2001 to 2015. Patients who
died in the PICU after the life-support limitation (LSL)
decision were included. Patients who died after brain
death or after unsuccessful cardiopulmonary resuscita-
tion were excluded because LSL is not applicable. The
unit’s specific algorithm for EOL care did not change
over time (Fig. 1). During the study, there was no spe-
cific protocol for PICU admission criteria for these pa-
tients. The decision was individualized according to the
situation of each patient.
Two groups were established: the pre-palliative group,
which included patients who died between 2001 and
2008, and the post-palliative group, which included
those who passed away between 2009 and 2015. The
reason for this temporary division was the further devel-
opment of the Palliative Care Unit in our hospital in
2009, when a specific multidisciplinary team was estab-
lished consisting of doctors, nurses, and psychologists.
Data from the pre-palliative group were partially pub-
lished [12]. The hospital’s Ethics Committee and the In-
stitutional Review Board approved the study. Informed
consent was not collected because of the retrospective
nature of the study.
LSL includes both the withdrawal or withholding of
life-sustaining measures and do-not-resuscitate (DNR)
orders. The withdrawal and withholding of life-
sustaining measures have been well-defined in the litera-
ture since the 1990s [13]. Withdrawal of treatment was
defined as discontinuing the life-sustaining intervention/
treatment that was already in place. Withholding treat-
ment was defined as the ‘non-initiation’ or the decision
not to escalate a life-sustaining treatment [8, 14]. These
two decisions were made after evaluating the patients’
prognosis and/or potential quality of life after surviving
the critical episode. A poor prognosis was considered as
the lack of an acceptable quality of life in the future after
the critical episode. Each patient was evaluated individu-
ally by the medical team (including the nurse) together
with the family. In this evaluation, the underlying dis-
ease, the prior quality of life, and the expected suffering
secondary to the sequelae / pathology were considered.
Data collection was performed by reviewing the med-
ical records. Epidemiological data and data about the
decision-making process during EOL care were col-
lected: gender, age, underlying disease, reason for admis-
sion, reason for LSL (the evolution of the underlying
pathology, poor prognosis, neurological sequelae), who
asked for LSL (medical team, family, both), need to con-
sult the Ethics Committee, what was decided (with-
drawal, withholding of support, or DNR order), how
supports were withdrawn, and the sedation strategy. Due
to our local protocol, all the information was recorded
in detail by the physician responsible for the patient,
who was the same physician who participated in the
decision-making process and communicated with the
family.
The categorical variables were expressed as frequency
and percentage, and the continuous variables as median
and interquartile range (IQR). The Chi-square test was
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used to compare categorical variables, and the Mann-
Whitney U test was utilized for continuous variables. A
value of p < 0.05 was considered statistically significant
(SPSS23®).
Results
During the 15 years of this study, 14,506 patients were ad-
mitted to the PICU and 480 patients died in the PICU
(3.3%). LSL was decided in 175 patients, with this repre-
senting 36.5% of the deaths in the PICU. Figure 2 includes
the distribution of overall deaths and deaths after LSL in
the PICU. Eighty-nine (50.9%) of the children who died
were female. The median age was 1 year old (IQR 0.3–
4.65). A previous pathology was present in 152 patients
(86.9%). The most frequent pathologies were neurological
diseases (61 patients, 40.1%), followed by metabolic diseases
(28 patients, 18.4%) and oncological diseases (22 patients,
14.5%). The main reason for admission was respiratory fail-
ure (86 patients, 49.1%). The median time spent in the
PICU until death was 6 days (IQR 2–13). See Table 1.
The most frequent reason for deciding LSL was the
unfavorable evolution of the underlying pathology (83
Fig. 1 Algorithm for the end-of-life decision-making process at the unit. *The palliative care unit and the pediatric intensive care unit share the
same physicians. PICU, Pediatric Intensive Care Unit; LST, life-sustaining treatment; DNAR, do not attempt resuscitation
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patients, 47.4%). The main underlying pathology in these
latter patients was neurological disease (38 patients,
46.3%), followed by metabolic disease (19 patients,
23.2%), oncological disease (7 patients, 8.5%), and car-
diac disease (6 patients, 7.3%). The second most com-
mon reason for LSL was poor prognosis (54 patients,
30.9%) and the third was neurological sequelae (35 pa-
tients, 20%). There were no differences between the two
groups as regards the reasons for deciding LSL, all with
p-values of > 0.05 (data included in Table 1). The med-
ical team proposed LSL in 145 cases (82.8%). The family
made the request in 10 cases (5.7%), with differences be-
tween the groups: 9 patients (8.9%) in pre-palliative
group versus 1 patient (1.4%) in post-palliative group
(p = 0.019). There was no data about this in 18 cases
(10.3%). The family agreed on the decision in the case of
157 patients (89.7%). The Ethics Committee was con-
vened in 4 cases (2.3%), three of them in the pre-
palliative group: in two cases the medical team did not
reach a consensus with the family (a patient with vascu-
lar infiltration after the recurrence of an underlying neo-
plasia and a patient affected by Tay-Sachs disease with
great neurological deterioration). The families requested
the continuation of support / treatment that the medical
team considered non-beneficial. In the other case, the
request was made by the family to reaffirm the with-
drawal action (limited to remove hydration and nutri-
tional support). The last patient was under the
guardianship of social services. Judicial intervention was
not needed in any case.
Withdrawal was the most frequent LSL (113 patients,
64.6%). Statistically significant differences were detected
between withdrawal and withholding over time (Table 1).
There were no differences between previously healthy
children and children with underlying diseases as regards
the decision to withdrawal of support (in healthy children:
17, 77.3%; and in children with an underlying disease: 96,
63.6%, with p = 0.207) or DNR order (in healthy children:
4, 18.8%; and in children with an underlying disease: 19,
12.6%, with p = 0.470). However, there were differences
between previously healthy children and children with
underlying diseases as regards the decision to withhold
support (in healthy children: 1, 4.5%; and in children with
an underlying disease: 36, 23.8%, with p = 0.039).
Focusing on the withdrawal strategy (Table 2), the de-
crease in inotropic support was the main measure in
terms of percentage (46 patients of the 71 who needed
that support, 64.7%). Oxygen was required in 150 pa-
tients and mechanical ventilation in 128 and removed in
73 (48.7%) and 51 (39.8%), respectively.
In reference to treatment for analgesia and sedation,
the combination of opioid drugs (morphine/fentanyl)
and midazolam was the most frequent (92 patients,
52.6%), followed by opioids alone (19 patients, 10.9%),
midazolam alone (12 patients, 6.9%), opioids and propo-
fol (10 patients, 5.7%), midazolam with propofol (10 pa-
tients, 5.7%), propofol alone (6 patients, 3.4%), and none
(4 patients, 2.3%). A necropsy was offered to all families
and sixty-four accepted (36.6%). Thirteen patients be-
came organ/tissue donors (7.4%).
Discussion
This study provides the LSL experience in a single PICU
and includes a large number of cases. A temporal
Fig. 2 Distribution of patients in the different groups. The proportion of deaths after the life-support limitation (LSL) decision is included with
respect to the total number of deaths (%)
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Table 1 Summary of the main characteristics of the sample, including the two groups
General data All (n = 175) Pre-palliative group (n = 101) Post-palliative group (n = 74) p
Sex, malea 85 (48.6%) 46 (45.5%) 39 (52.7%) 0.420
Median age, yearsb 1 (0.3–4.65) 0.81 (0.31–5.43) 1 (0.38–4.25) 0.948
Underlying diseasea 152 (86.9%) 88 (87.1%) 64 (86.5%) 0.901
Cardiac 22 (12.6%) 11 (10.9%) 11 (14.9%) 0.001
Respiratory 6 (3.4%) 0 6 (8.1%)
Neurological 61 (34.9%) 43 (42.6%) 18 (24.3%)
Oncologic 22 (12.6%) 11 (10.9%) 11 (14.9%)
Metabolic 28 (16%) 20 (19.8%) 8 (10.8%)
Others 13 (7.4%) 3 (3%) 10 13.5%)
Reason for admissiona
Cardiac arrest 19 (10.9%) 16 (15.8%) 3 (4.1%) 0.328
Respiratory insufficiency 86 (49.1%) 45 (44.6%) 41 (55.4%)
Cardiac decompensation 13 (7.4%) 7 (6.9%) 6 (8.1%)
Sepsis 21 (12%) 13 (12.9%) 8 (10.8%)
Intracranial hypertension 6 (3.4%) 3 (3%) 3 (4.1%)
Others 29 (16.6%) 17 (16.8%) 12 (16.2%)
Length of stay, daysb 6 (2–13) 4 (2–12.5) 7 (3–14.25) 0.011
Reason for LSLa
Unfavorable evolution of underlying disease 83 (47.4%) 51 (50.5%) 32 (43.2%) 0.319
Poor prognosis 54 (30.9%) 31 (30.7%) 23 (31.1%) 0.978
Neurological sequelae 35 (20%) 17 (16.8%) 18 (24.3%) 0.228
Life-support limitationa
Withdrawal 113 (64.6%) 58 (57.4%) 55 (74.3%) 0.031
Withholding 37 (21.1%) 31 (30.7%) 6 (8%) 0.000
Do-not-resuscitate order 23 (13.1%) 10 (9.9%) 13 (17.6%) 0.152
Necropsy 64 (36.6%) 35 (34.6%) 29 (39.2%)
Organ or tissue donation 13 (7.4%) 11 (10.9%) 2 (2.7%) 0.036
aCategorical variable, expressed as frequency (%), Chi-square test. bContinuous variable, expressed as median (IQR), Mann-Whitney U test. LSL: life-support limitation
Table 2 Life-sustaining treatments and devices required and removed
Support All (n = 175) Pre-palliative group groupgroupgroup (n = 101) Post-palliative group (n = 74) p
Inotropic
Required 68 (38.9%) 45 (44.6%) 26 (35.1%)
Removed 44 (64.7%) 32 (71.1%) 14 (53.8%) 0.046
Oxygen
Required 142 (81.1%) 82 (81.2%) 68 (91.9%)
Removed 71 (50.4%) 38 (46.3%) 35 (47.3%) 0.221
MV
Required 121 (69.1%) 74 (73.3%) 54 (72.9%)
Removed 49 (40.2%) 35 (47.3%) 16 (29.6%) 0.052
ECMO
Required 3 (1.7%) 0 (0%) 3 (4.1%)
Removed 3 (100%) 0 3 (100%) 0.039
Values expressed as frequency (percentage). MV mechanical ventilation, ECMO extracorporeal membrane oxygenation
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division was used to split the sample into two groups.
The reason for this division was to analyze the impact of
improving palliative care in our center.
Worldwide, the number of deaths in PICUs decreased
to less than 3% during the study window [15], similar to
our data. A decrease in the number of deaths in the
PICU over time was observed, with fewer deaths in the
post-palliative group. However, the frequency of LSL
with respect to the total number of deaths was higher in
the post-palliative group. The training of the medical
team in palliative care could explain this change. The
LSL decision allows physicians to avoid providing non-
beneficial treatments to patients at the end of their lives,
and it is essential to identify which patients are in this
situation. In 2009, the Palliative Care Unit of our center
was improved. More pediatricians and nurses joined the
unit and tele–health care and home visits were started.
In some units, the EOL in the PICU is planned and
guided by the palliative care team [16], although the rec-
ommendation nowadays is that intensivists be trained to
assess and manage palliative care needs to provide a
“good” EOL to the patients and their families [5, 17, 18].
In our unit, the intensivist managed EOL care. Palliative
physicians and intensivists also work together in those
situations in which intensive care could provide comfort
at the end of a patient’s life. Some criteria for palliative
care in the PICU were recently published [19]. Differ-
ences according to epidemiological characteristics be-
tween our results and other previous studies were not
detected. The number of patients with underlying path-
ologies remained stable (85%) [20], however there were
fewer patients with metabolic or neurological diseases in
the post-palliative group, possibly due to the support of
palliative care teams allowing patients to die in alternate
locations, such as at home or in a general ward [21–23].
This improvement may reflect the work of the Palliative
Care Unit, as they often facilitate EOL care at home or
in the general wards.
The main reason for admission was respiratory failure,
a weak point for patients with advanced chronic diseases
[12, 24, 25]. The decision to initiate LSL was mainly
conditioned by the evolution of the underlying disease,
followed by a poor prognosis, without differences over
time. As described in the recent report by Butt [26], the
withdrawal of life-sustaining measures and the DNR
order did not differ between previously healthy children
and children with underlying diseases. However, with-
holding was more frequent in children with underlying
diseases. The decision to withdraw treatments or to
issue the DNR order is also difficult for families with
previously ill children. By contrast, withholding can be
planned beforehand in families with severely disabled
children. LSL changed over time: the proportion of life-
sustaining measures being withheld was higher in the
pre-palliative group than in the post-palliative group,
and this may be explained by the type of chronic pa-
tients in each group, with more patients having neuro-
logical and metabolic impairment in the pre-palliative
group. The fact that the Palliative Care Unit was in-
volved is important because non-admission to the PICU
may also be seen as a measure of life support withhold-
ing. This change over time could also be justified by the
training of the medical team in LSL. The withdrawal or
withholding of life support are generally considered
moral and ethical equals [27]. In recent years, the med-
ical team has been inclined to attempt life-sustaining
measures for a limited time. If a good response was not
observed, then those life-sustaining measures were with-
drawn. As in previous studies, families participated in
the decision-making process for the LSL [24, 28]. A
study published in 2004 that compared the decision-
making process in northern and southern European
countries suggested that there were differences in the in-
formation received by families because of the influence
of the cultural roots of the different countries [25]. In
our institution, the information was detailed and adapted
to the degree of understanding of each family. Families
participated in the LSL decision-making process in a
high percentage of the cases. There are fewer requests
for LSL from parents in recent years, possibly because
the medical team has introduced LSL gradually over
time. The flow of information also varied based on the
capacity of the family to understand this information.
There may be differences in opinion between the family
and the clinicians regarding the optimal care for the
child. The family may not accept the child’s situation
and may request to continue with curative treatments
instead of focusing on comfort and EOL care [29, 30].
The Ethics Committee was convened on only 4 occa-
sions in the past 15 years, suggesting a high degree of
agreement between families and the medical team. The
Ethics Committee is a consultative and interdisciplinary
group; it is formed by professionals trained in bioethics
that advises on the resolution of ethical conflicts that
may arise during healthcare provision. The decision of
the Ethics Committee is not binding. Even so, in the two
cases in which it was convened due to the lack of agree-
ment between the medical team and the family, the
Committee supported the decision made by the medical
team and the families accepted that decision without the
mediation of the courts or a judge’s order.
The time elapsed from PICU admission until the LSL
decision varies according to the study reviewed. In some
units, the median number of days is less than 3 [31] and
in others it ranges to more than 3 weeks [24]. Cultural
and religious issues may explain this variability. Our data
showed less than 1 week until the LSL. The most fre-
quent mode of death was via the withdrawal of life
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support, similar to the data reported by Zawitowski [24].
This differs from other studies [26, 32, 33], perhaps be-
cause of cultural differences and the evolution of LSL
practices in the PICU. In absolute numbers, the support
most commonly removed was respiratory support, simi-
lar to other publications [34]. Inotropic support was
withdrawn in up to 65% of patients requiring it. These
data are similar to those reported in previous studies
[24]. Extracorporeal life support was withdrawn in all
cases. As has been observed in other studies, the with-
drawal of medically administered nutrition support was
not generally considered in the PICU [35–37]. Sedation
to ensure a dignified EOL for these patients is a funda-
mental concern. As in other studies [12, 24], opioids
were the main analgesics used. They were used in con-
junction with midazolam in more than 50% of the cases.
Four patients received no sedatives, all of them with se-
vere neurological damage. No patients were treated with
neuromuscular blocking agents during the EOL process,
which is a controversial treatment [20, 38]. No specific
sedation scale for EOL was used in this study.
The main limitation of this study is its retrospective
design. This factor could make the results quite variable,
as data may not be accurately reflected in the medical
documentation. Also, the granularity of the data and the
single-center design are limitations, although this con-
fers homogeneity to the study: the same standardized
approach for determining the goal of EOL care was ap-
plied. It is important to note that the analysis of the im-
pact of the Palliative Care Unit in a hospital is not
complete without taking into account those patients
who are managed in a general hospital ward or at home.
However, this study focuses on patients cared for in the
PICU, since the development of the Palliative Care Unit
also influences care within this setting.
In conclusion, fewer children died in our PICU in recent
years, and the LSL proportionally increased, although the
percentage is still relatively low. A large percentage of the
cases had a chronic disease. The main cause of LSL in the
PICU was the unfavorable evolution of the underlying
pathology. Families were involved in the EOL decision-
making process. Withdrawal was the most frequent LSL.
Withdrawing mechanical ventilation and oxygen were the
main actions taken. Undoubtedly, the focus on holistic,
compassionate, and child-centered care within the PICU
helps achieve a dignified EOL in which the parents are
also involved in the decision-making process and the care
provided to their children. Increased confidence among
the clinicians working in the PICU when providing EOL
care, as well as the availability of a Palliative Care Unit,
contribute to this improvement in quality EOL care.
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